Sheba Medical Center has recently implemented a revolutionary new technology that is changing the way they handle biopsy tests for cancer patients. The development, created by the promising Tel Aviv start-up company imagene, utilizes artificial intelligence (AI) to identify countless characterizations of cancerous tumors within minutes. This technology has greatly improved the process of diagnosing and treating cancer patients at Sheba Medical Center, saving lives in the process.
Until recently, biopsy samples were transferred between laboratories on fragile glass, making it difficult to view and analyze them quickly. However, with the implementation of digital scanning technology at Sheba Medical Center, doctors can now view biopsy samples even from home and anywhere in the world. This has allowed for quicker diagnosis and treatment options for patients, reducing wait times and potentially saving lives.
The AI technology used by imagene works by scanning thousands of different algorithms to identify the characteristics of tumors and mutations present in them. Within a few minutes, an indication of the type of cancer is received so that the medical team knows what treatment and exact dose to give the patient. This has greatly streamlined the process of diagnosing and treating cancer patients at Sheba Medical Center.
Professor Iris Brashak, director of the pathology laboratory at Sheba Medical Center and chairman of the Israeli Pathology Association, was instrumental in implementing this new technology. “Since we switched to digital scanning of biopsies,” she says, “we have been able to provide quick answers to our patients even when we are not in the laboratory or consulting with experts from all over the world.” The use of AI technology has truly revolutionized this field and saved countless lives at Sheba Medical Center.